Cargando…
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
BACKGROUND: Women with pathogenic BRCA1 or BRCA2 variants are at high risk for breast and ovarian cancer. Preventive options include risk-reducing breast and ovarian surgeries and intensified breast surveillance. However, individual decision-making is often associated with decisional conflicts. Two...
Autores principales: | Kautz-Freimuth, Sibylle, Redaèlli, Marcus, Shukri, Arim, Kentenich, Hannah, Simic, Dusan, Mildenberger, Vanessa, Schmutzler, Rita, Rhiem, Kerstin, Stock, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580583/ https://www.ncbi.nlm.nih.gov/pubmed/37845719 http://dx.doi.org/10.1186/s12911-023-02327-9 |
Ejemplares similares
-
Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2022) -
Decision Aids for Preventive Treatment Alternatives for
BRCA1/2
Mutation Carriers: a Systematic Review
por: Krassuski, Lisa Marlene, et al.
Publicado: (2021) -
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021) -
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
por: Krassuski, Lisa, et al.
Publicado: (2019) -
“You Always Have It in the Back of Your Mind”—Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study
por: Stracke, Claudia, et al.
Publicado: (2022)